The market is expected to show rapid growth due to the rising incidence of chronic and lifestyle-related disorders, the rising number of imaging and diagnostic centers, and the increased adoption of point-of-care and rapid diagnostic tests coupled with collaborations and partnerships by players.
[270 Pages Report] The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901
Report Scope and Market Segmentation:
Report Metric | Details |
Market Size Available for Years | 2019–2026 |
Base Year Considered | 2020 |
Forecast Period | 2022–2026 |
Forecast Units | Value (USD Billion) |
Segments Covered | Application, End User |
Geographies Covered | North America, Europe, APAC, Latin America and Middle East Africa |
Companies Covered | Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Siemens AG (Germany), PerkinElmer, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), bioMérieux SA (France), Koninklijke Philips N.V. (Netherlands), Guided Therapeutics, Inc. (US), SuperSonic Imagine (France), FUJIFILM Holdings Corporation (Japan), DIALAB GmbH (Austria), Carestream Health, Inc. (US), MedGyn Products, Inc. (US), Cook Medical, Inc. (US), Osteometer MediTech, Inc. (Denmark), and NeuroLogica Corporation (US) |
The prenatal genetic screening carrier testing segment is expected to grow at the highest CAGR during the forecast period
Based on application, the women’s health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy fertility testing, prenatal genetic screening carrier testing, infectious disease testing, STD testing, and ultrasound tests.
The hospitals clinics segment is expected to account for the largest share of the women’s health diagnostics market
Based on end user, the women’s health diagnostics market is segmented into hospitals clinics, diagnostic imaging centers, and home care settings. The hospitals clinics segment accounted for the largest share of the women’s health diagnostics market
Asia Pacific is expected to account for the highest CAGR for players operating in the women’s health diagnostics market
The Asia Pacific women’s health diagnostics market is expected to grow at the highest CAGR from 2020 to 2025. Improving healthcare infrastructures, growing per capita incomes, and the rising focus of key market companies in this region are major factors driving the growth of the APAC women’s health diagnostics market.
Hologic, Inc. holds the leading position in the women’s health diagnostics market, owing to its robust portfolio of breast imaging products and related accessories. Hologic has expanded its product portfolio through insight-driven innovation and strategic MAs to establish its position in the market.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901
